Profile photo Bart de Keizer

Bart de Keizer

Research Staff Other

Strategic program(s):

Biography

Bart de Keizer is a highly skilled radiologist and nuclear medicine physician  affiliated with UMC Utrecht and the Princess Máxima Center for Pediatric Oncology in Utrecht, the Netherlands. He completed his medical degree at UMC Utrecht in 2002, followed by a PhD in Nuclear Medicine in 2004. Dr. de Keizer holds board certifications in both nuclear medicine (2006) and radiology (2015). With over two decades of experience, he plays a pivotal role in imaging departments, combining expertise in both adult and pediatric oncology care. Dr. de Keizer continues to contribute to advancements in medical imaging and treatment. a distinguished researcher in oncology with a specialization in nuclear therapy and diagnostic imaging. His expertise spans a range of cancers, including thyroid cancer, head and neck cancer, and pediatric oncology. 

Research and Publications

Dr. de Keizer's research is dedicated to advancing the diagnostics of oncological diseases. By evaluating current diagnostic scans and introducing new imaging techniques, his work aims to enable image-guided treatments that could increase the cure rates for cancer patients.

In recent years, Dr. de Keizer has been instrumental in the introduction of several new radioactive tracers and PET scans. Notable examples include:

  • Fluor-18-choline PET-CT for detecting parathyroid adenomas
  • Gallium-68-tilmanocept PET-CT for sentinel lymph node detection
  • Fluor-18-MFBG for detecting neuroblastoma
 
 
 

 

 

Associate Professor lecture

Nieuwe scantechnieken voor beeldgestuurde interventies": https://www.youtube.com/watch?v=97FmYAa8LuE

Strategic program(s):

Contact

Research groups

Decision support systems for precision care in translational cancer-imaging

Research aim

To develop, validate and implement decision support systems based on imaging for the diagnosis, prognosis and triaging of oncology patients

Go to group

Advanced imaging for oncology group

Research aim

To enhance patient outcomes through improved cancer staging, enabling personalized treatments with advanced diagnostics.

Go to group

Recent publications

Lymph Node Staging and Treatment in Pediatric Patients With Soft Tissue Sarcomas Sheila Terwisscha van Scheltinga, Reineke A. Schoot, Jonathan C. Routh, Guido Seitz, Simon C. Kao, Bart de Keizer, Barry Shulkin, Roelof van Ewijk, Beth McCarville, Dana Casey, Wendy Allen-Rhoades, Federico Mercolini, Hans Merks, Daniel Orbach, Tejas Kapadia, David O. Walterhouse, Raquel Davila Fajardo, Laura Hiemcke-Jiwa, Christiane Franzius, Federica De Corti, Vivian Tang, Jonathan Metts, Saphna Oberoi, Christian Vokuhl, Roshni Dasgupta, Suzi Birz, David Rodeberg
Pediatric Blood and Cancer, 2025, vol. 72
Assessment of the risk of malignancy in Bethesda III thyroid nodules Karthik Nagaraja Rao, Gregory W. Randolph, Fernando Lopez, Mark Zafereo, Andrés Coca-Pelaz, Cesare Piazza, Prajwal Dange, Juan Pablo Rodrigo, Göran Stenman, Bart de Keizer, Iain Nixon, Shriyash Sinha, Sophie Leboulleux, Antti A. Mäkitie, Abbas Agaimy, Lester Thompson, Alfio Ferlito
Endocrine, 2024, vol. 85, p.473–492
Considerations for SUV measurement in PSMA PET/CT reporting Bart de Keizer, Arthur J.A.T. Braat, Marnix G.E.H. Lam, Rob van Rooij
European Journal of Nuclear Medicine and Molecular Imaging, 2024, vol. 52, p.386-387
Frontline and Relapsed Rhabdomyosarcoma (FAR-RMS) Clinical Trial Julia Chisholm, Henry Mandeville, Madeleine Adams, Veronique Minard-Collin, Timothy Rogers, Anna Kelsey, Janet Shipley, Rick R. van Rijn, Isabelle de Vries, Roelof van Ewijk, Bart de Keizer, Susanne A. Gatz, Michela Casanova, Lisa Lyngsie Hjalgrim, Charlotte Firth, Keith Wheatley, Pamela Kearns, Wenyu Liu, Amanda Kirkham, Helen Rees, Gianni Bisogno, Ajla Wasti, Sara Wakeling, Delphine Heenen, Deborah A. Tweddle, Johannes H.M. Merks, Meriel Jenney
Cancers, 2024, vol. 16
A narrative review of 35 years of meta-[131I]iodobenzylguanidine therapy in neuroblastoma Atia Samim, Gitta Bleeker, Kathelijne C.J.M. Kraal, Max M. van Noesel, Bart de Keizer, Godelieve A.M. Tytgat
EJC Paediatric Oncology, 2024, vol. 3
One step closer to the end of postoperative radioactive iodine thyroid remnant ablation Frederik A. Verburg, Bart de Keizer
The Lancet Diabetes and Endocrinology, 2024, vol. 13, p.5-6